TeloNostiX

TeloNostiX is an in vitro diagnostics company that offers telomere length analysis for clinical and research applications. Their technologies are used for the prognosis and prediction of treatment responses in cancer patients and other telomere-related disorders.
  • Single Molecule STELA
  • High-Throughput STELA
Size
Small
Phone
02922 510 443
Website
telonostix.com
Email
Available in Endole App
Locations
Henry Wellcome Bldg, Heath Park Way, CF14 4XN
02922510443
Digital Popularity
Social Media
Company Details
TeloNostiX is operated by Telonostix Ltd and is a Active company incorporated on 30 October 2015 with the registered office located in Cardiff, South Glamorgan. Telonostix Ltd was registered 10 years ago.
Status
Active
Size
Micro
Directors
5
Age
10 years old
Employees
1
Turnover
Unreported
Total Assets
£129.27K
Cash in Bank
£93.55K
Total Liabilities
-£96.55K
Christopher Fegan
Director • British • Lives in Wales • Born in Nov 1960
Dr Rhodri Thomas Owain Turner
Director • British • Lives in Wales • Born in Mar 1984
Professor Duncan Martin Baird
Director • British • Lives in Wales • Born in Feb 1971
Dr Joseph Thomas Birkett
Director • British • Lives in England • Born in May 1970
Professor Christopher Pepper
Director • British • Lives in England • Born in Jan 1968
Professor Duncan Martin Baird
PSC • British • Lives in Wales • Born in Feb 1971
More information on Telonostix Ltd
Teams
All
3
Joseph Birkett
CEO • Joined Dec 2017
Duncan Baird
Chief Technology Officer • Joined Sep 2015
Kevin Norris
Research Director • Joined May 2018